Literature DB >> 32479692

Infections or Sepsis Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study.

Shemonti Hasan1, Michelle M Mielke1,2, J Eric Ahlskog1, James Bower1, Pierpaolo Turcano1, Rodolfo Savica1,2.   

Abstract

BACKGROUND: Several studies have proposed a role for infections to induce an inflammatory response triggering Parkinson's disease. This remains controversial and the influence of severe infections on other α-synucleinopathies (Dementia with Lewy Bodies, Parkinson's disease dementia, and Multiple System Atrophy) has not been adequately investigated.
OBJECTIVES: To assess the association between hospitalization-required infections or sepsis and risk of clinically diagnosed α-synucleinopathies.
METHODS: Using the medical records-linkage system (Rochester Epidemiology Project), we identified all α-synucleinopathy cases of in Olmsted County (1991-2010). Cases were matched by symptom-onset age and sex to controls. We reviewed complete medical records to detect hospital-required infections or sepsis preceding clinical-motor onset of α-synucleinopathies. We used conditional logistic regression to calculate the odds ratio of all α-synucleinopathies, adjusting for medications, coffee, and smoking.
RESULTS: There was no association between infection-related hospitalization (odds ratio: 1.05; 95% confidence interval: 0.78-1.40; P = 0.76) or sepsis (odds ratio: 0.86; 95% confidence interval: 0.40-1.85; P = 0.70) and all α-synucleinopathies in multivariable analyses. We did not identify any associations after stratifying for type of α-synucleinopathy, sex, and age at clinical-motor onset. We analyzed sepsis separately with similar results.
CONCLUSION: We did not observe any associations between infections leading to hospitalization or sepsis and development of any α-synucleinopathies.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  case-control; infection; parkinsonism; sepsis; α-synucleinopathies

Mesh:

Substances:

Year:  2020        PMID: 32479692      PMCID: PMC7818650          DOI: 10.1002/mds.28111

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.

Authors:  Liya Qin; Xuefei Wu; Michelle L Block; Yuxin Liu; George R Breese; Jau-Shyong Hong; Darin J Knapp; Fulton T Crews
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

3.  The association between infectious burden and Parkinson's disease: A case-control study.

Authors:  Xian-Le Bu; Xin Wang; Yang Xiang; Lin-Lin Shen; Qing-Hua Wang; Yu-Hui Liu; Shu-Sheng Jiao; Ye-Ran Wang; Hong-Yuan Cao; Xu Yi; Cheng-Hui Liu; Bo Deng; Xiu-Qing Yao; Zhi-Qiang Xu; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Parkinsonism Relat Disord       Date:  2015-05-30       Impact factor: 4.891

4.  Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.

Authors:  J H Bower; D M Maraganore; B J Peterson; J E Ahlskog; W A Rocca
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

5.  Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.

Authors:  Pierpaolo Turcano; Michelle M Mielke; Keith A Josephs; James H Bower; Joseph E Parisi; Bradley F Boeve; Rodolfo Savica
Journal:  Mov Disord       Date:  2017-08-26       Impact factor: 10.338

6.  Time Trends in the Incidence of Parkinson Disease.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

7.  CNS infections, sepsis and risk of Parkinson's disease.

Authors:  Fang Fang; Karin Wirdefeldt; Andreas Jacks; Freya Kamel; Weimin Ye; Honglei Chen
Journal:  Int J Epidemiol       Date:  2012-04-19       Impact factor: 7.196

8.  Incidence of dementia with Lewy bodies and Parkinson disease dementia.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; Bradley F Boeve; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

Review 9.  When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review.

Authors:  Rodolfo Savica; Bradley F Boeve; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

10.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

Authors:  Viktor Y Dombrovskiy; Andrew A Martin; Jagadeeshan Sunderram; Harold L Paz
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

View more
  1 in total

Review 1.  Epidemiological Evidence for an Immune Component of Parkinson's Disease.

Authors:  Paulina Gonzalez-Latapi; Connie Marras
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.